Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eureka 93 was a Canada-based, vertically integrated CBD and hemp-derived cannabinoid company formed from the combination of LiveWell Canada, Acenzia, and Vitality CBD Natural Health Products. The company focused on research, extraction, formulation, manufacturing, and distribution of hemp-derived cannabidiol ingredients and consumer health, wellness, and beauty products. Its operating footprint included extraction in Montana and New Mexico, manufacturing in Windsor, Ontario, and research and development in Gatineau, Quebec. Eureka 93 marketed itself as one of the larger North American hemp CBD extraction platforms, offering full plant extract, full spectrum distillate, isolate powder, and natural health product manufacturing capabilities. Despite its commercial positioning, the company encountered significant financial distress in 2020, including insolvency proceedings and a trading suspension, and it does not appear to be operating as an active growth-stage life sciences business today.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eureka 93.